Wolfgang Rottbauer
Overview
Explore the profile of Wolfgang Rottbauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
328
Citations
6891
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von Sanden F, Skrabal C, Arab M, Liebold A, Rottbauer W, Buckert D
JACC Case Rep
. 2025 Mar;
30(5):103026.
PMID: 40054933
Background: Coronary artery fistulas (CAFs) are a rare congenital heart disease. Large fistulas can lead to coronary steal phenomena presenting with angina, heart failure, and in rare cases, cardiogenic shock....
2.
Pagnesi M, Adamo M, Stolz L, Pancaldi E, Kresoja K, von Stein J, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39980251
Aims: The impact of malnutrition in patients with tricuspid regurgitation (TR) undergoing tricuspid transcatheter edge-to-edge repair (T-TEER) is not well established. We evaluated the impact of malnutrition among patients with...
3.
Scheffler J, Ott J, Landes M, Felbel D, Groger M, Kessler M, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941465
Transcatheter tricuspid edge-to-edge repair (T-TEER) is widely used to treat atrial (AFTR) and ventricular (VFTR) functional tricuspid regurgitation (FTR). The outcome of 136 patients treated with T-TEER for severe AFTR...
4.
Katov L, Rostan J, Teumer Y, Diofano F, Bothner C, Rottbauer W, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941457
: In recent years, sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated significant cardiovascular and renal benefits in patients with heart failure (HF), in addition to their established antidiabetic effects. However, their...
5.
Schlotter F, Stolz L, Kresoja K, von Stein J, Fortmeier V, Koell B, et al.
JACC Cardiovasc Interv
. 2025 Feb;
18(3):339-348.
PMID: 39939038
Background: Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as a treatment option for patients with severe tricuspid regurgitation (TR). However, randomized trials have not shown a survival benefit, possibly because...
6.
Voll F, Olivecronab G, Ferenc M, Hellig F, Schlundt C, Wohrle J, et al.
Cardiovasc Interv Ther
. 2025 Feb;
40(2):296-305.
PMID: 39918675
New-generation single-layer polytetrafluorethylene (PTFE-) or polyurethane (PU-) covered stent (CS) for the treatment of coronary artery perforation (CAP) during PCI offer high procedural efficacy. To evaluate the comparative long-term safety...
7.
Felbel D, Fackler S, Michalke R, Paukovitsch M, Groger M, Kessler M, et al.
BMC Cardiovasc Disord
. 2025 Jan;
25(1):37.
PMID: 39849376
Background: ST-elevation myocardial infarction (STEMI) demands near-time reperfusion to reduce the risk of long-term heart failure. This study evaluates the proportion of impaired left ventricular ejection fraction (LVEF) following STEMI...
8.
von Stein P, Stolz L, Haurand J, Groger M, Rudolph F, Mustafa D, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(5):573-586.
PMID: 39745410
Background: The PASCAL P10 system for mitral valve transcatheter edge-to-edge repair has undergone iterations, including introduction of the narrower Ace implant and the Precision delivery system. Objectives: This study sought...
9.
Katov L, Teumer Y, Bothner C, Rottbauer W, Weinmann-Emhardt K
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685499
Pulsed field ablation (PFA) represents a novel non-thermal approach for treating atrial fibrillation (AF) through pulmonary vein isolation (PVI). By utilizing irreversible electroporation, PFA creates lesions with minimal impact on...
10.
Stolz L, Kresoja K, von Stein J, Fortmeier V, Koell B, Rottbauer W, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(23):2781-2791.
PMID: 39663058
Background: Atrial secondary tricuspid regurgitation (A-STR) has been proposed as an important etiologic subentity of secondary tricuspid regurgitation (STR). Patients with A-STR are frequently treated using transcatheter tricuspid valve edge-to-edge...